Analyst Ratings for Onconova Therapeutics (ONTX)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/21/2023 | H.C. Wainwright | Joseph Pantginis | Upgrade | Buy (N/A) |
11.00 (N/A) |
0.70 (1.00) |
42.86% | Details |
3/1/2022 | Ladenburg Thalmann | Ahu Demir | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.62 (1.00) |
-38.27% | Details |